Document is current

Article History

Received: 18 September 2020

Revised: 14 December 2020

Accepted: 5 January 2021

First Online: 6 February 2021

Compliance with ethical standards

:

: <i>N. Eter</i>: consultant: Novartis, Bayer; speaker fees and honoraria: Novartis, Bayer, Allergan; research fund: Novartis, Bayer; study grant to the department: Novartis, Bayer; advisory board: Novartis, Bayer, Allergan, Alimera Sciences, Roche. <i>G. Keramas</i>: employee: Bayer Vital GmbH. <i>C. Rech:</i> employee: Bayer Vital GmbH. <i>Z. Hasanbasic</i>: employee: Bayer Vital GmbH. <i>H. Sachs</i>: consultant: Alcon Laboratories, Inc., Allergan, Retina Implant AG, Bayer, Novartis; patents/royalty: Retina Implant AG; grant support: Retina Implant AG. <i>H. Schilling</i>: lecture fees: Bayer Vital GmbH, Allergan. <i>J. Wachtlin</i>: consultant: Alcon Laboratories, Inc., Allergan, Retina Implant AG, Bayer, Novartis. <i>P. Wiedemann</i>: research grant: Novartis; study grants: Novartis, Bayer, Alcon, Allergan, Formycon, Ophthotech, Roche, Thrombogenics, Alimera. <i>C. Framme</i>: consultant: Allergan, Bayer, Heidelberg Engineering, Novartis, Zeiss; research grant: Novartis.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.